cholestyramine resin has been researched along with bpc 157 in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (bpc 157) | Trials (bpc 157) | Recent Studies (post-2010) (bpc 157) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 136 | 0 | 64 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aralica, G; Deskovic, S; Gjurasin, M; Grabarevic, Z; Hanzevacki, M; Jadrijevic, S; Jagic, V; Kocman, B; Miklic, P; Mikus, D; Mise, S; Patrlj, L; Perovic, D; Petek, M; Rotkvic, I; Rucman, R; Sarlija, M; Sebecic, B; Seiwerth, S; Separovic, J; Sikiric, P; Sosa, T; Turkovic, B; Ziger, T; Zoricic, I | 1 |
1 other study(ies) available for cholestyramine resin and bpc 157
| Article | Year |
|---|---|
Long-lasting cytoprotection after pentadecapeptide BPC 157, ranitidine, sucralfate or cholestyramine application in reflux oesophagitis in rats.
Topics: Animals; Anti-Ulcer Agents; Cholestyramine Resin; Esophagitis, Peptic; Female; Gastric Mucosa; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Sucralfate; Time Factors | 1999 |